News
$CTOR CTOR CTXR - Citius Oncology's Positive Quality of Life Data for LYMPHIR® (denileukin diftitox-cxdl) in Relapsed or Refractory Cutaneous T-Cell L
Nov 4, 2026 · ThinkSabio Blog
$CTOR CTOR CTXR - Citius Oncology's Positive Quality of Life Data for LYMPHIR® (denileukin diftitox-cxdl) in Relapsed or Refractory Cutaneous T-Cell Lymphoma Presented at Premier Global CLTG Congress in Europe
04-NOV-2026 01:46 PM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
